A newly synthesised biocompatible therapeutic nano-micelle drug delivery system combined with anti-inflammatory drugs has shown improved potential to cure rheumatoid arthritis at the lab level.
It can help ameliorate the pain associated with the disease as well as cure the disease by restoring cartilage integrity which provides the flexibility to the bone.
Nanomicelles are self‐assembling nanosized colloidal dispersions with a hydrophobic core and hydrophilic shell.
Owing to its size, solubility, customised surface or its exposure to the environment, nanomicelles show some unique or novel characteristics, which makes it multifunctional and thus makes its use indispensable in biomedical application and various other fields. These are currently used as pharmaceutical carriers for solubilizing hydrophobic drugs.
